Mankind Pharma Limited — Credit Ratings, 24-02-2026: Credit Rating- Revision
24-02-2026 | 06:21 pm
24-02-2026 | 06:21 pm
Mankind Pharma: ICRA Limited reaffirmed credit ratings for Non-Convertible Debentures (₹5,000 Cr) at (ICRA) AA+/Stable. Long-term/Short-term fund based limits (₹1,250 Cr) also reaffirmed at (ICRA) AA+ (Stable)/(ICRA)A1+. The outlook for these instruments remains Stable, reflecting consistent credit strength.
No comments yet. Be the first to comment!
